Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 55 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bortezomib/dexamethasone (Maxidex) | [2] Bortezomib Bortezomib,Dexamethasone (Maxidex) | [2] Dexamethasone
Dexamethasone
(Maxidex),Bortezomib 💬 1. Bortezomib/dexamethasone
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 283 283 💬1. Bortezomib/dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone (Maxidex) Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone (Max ... | [2] Bortezomib Bortezomib,Dexamethasone (Maxidex) | [2] Dexamethasone
Dexamethasone
(Maxidex),Bortezomib 💬 2. Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 28 28 💬2. Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Bupivacaine/epinephrine/dexamethasone (Maxidex) | [3] Bupivacaine Bupivacaine,Dexamethasone (Maxidex), Epinephrine | [3] Epinephrine
Epinephrine
,Dexamethasone (Maxidex), Bupivacaine 💬 3. Bupivacaine/epinephrine/dexamethasone
| [15] ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A ... 3. Bupivacaine/epinephrine/dexamethasone
| [16] AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 [16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | [1] 96 96 💬3. Bupivacaine/epinephrine/dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine (Maxidex) | [3] Azathioprine Azathioprine,Dexamethasone (Maxidex), Rituximab | [3] Azathioprine
Azathioprine
,Dexamethasone (Maxidex), Rituximab 💬 4. Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
| [2] MS4A1 MS4A1,NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 35 35 💬4. Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Control intervention (no dexamethasone) (Maxidex) | [1] Dexamethasone Dexamethasone (Maxidex) | [1] Dexamethasone
Dexamethasone
(Maxidex) 💬5. Control intervention (no dexamethasone)
| [1] NR3C1 NR3C1 💬5. Control intervention (no dexamethasone)
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 💬5. Control intervention (no dexamethasone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) (Maxidex) Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, predn ... | [7] Acetate Acetate,Cortisone, Cortisone acetate, Dexamethasone (Maxidex), Hydrocortisone, Prednisolone, Prednisone [7] Acetate, Cortisone, Cortisone acetate, Dexamethasone(Maxidex), Hydrocortisone, Prednisolone, Prednison ... | [6] Hydrocortisone
Hydrocortisone
,Dexamethasone (Maxidex), Prednisolone , Prednisone , Cortisone acetate , Cortisone 💬 [6] Hydrocortisone , Dexamethasone (Maxidex), Prednisolone , Prednisone , Cortisone acetat ... 6. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| [1] NR3C1 NR3C1 💬6. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬6. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen (Maxidex) | [3] Bortezomib Bortezomib,Cyclophosphamide, Dexamethasone (Maxidex) | [4] Cyclophosphamide
Cyclophosphamide
,Dexamethasone (Maxidex), Bortezomib , Cyclophosphamide 💬 7. Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 28 28 💬7. Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Cyclophosphamide, Bortezomib, dexamethasone (Maxidex) | [3] Bortezomib Bortezomib,Cyclophosphamide, Dexamethasone (Maxidex) | [4] Cyclophosphamide
Cyclophosphamide
,Dexamethasone (Maxidex), Bortezomib , Cyclophosphamide 💬 8. Cyclophosphamide, Bortezomib, dexamethasone
| [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | [1] 28 28 💬8. Cyclophosphamide, Bortezomib, dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab (Maxidex) | [4] Bortezomib Bortezomib,Cyclophosphamide, Daratumumab, Dexamethasone (Maxidex) | [5] Cyclophosphamide
Cyclophosphamide
,Dexamethasone (Maxidex), Bortezomib , Cyclophosphamide , Daratumumab 💬 [5] Cyclophosphamide , Dexamethasone (Maxidex), Bortezomib , Cyclophosphamide , Daratumuma ... 9. Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
| [3] CD38 CD38,NR3C1, PSMB5 💬 | [16] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 [16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell ... | [1] 28 28 💬9. Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Dexamethasone (Maxidex) | [1] Dexamethasone Dexamethasone (Maxidex) | [1] Dexamethasone
Dexamethasone
(Maxidex) 💬10. Dexamethasone
| [1] NR3C1 NR3C1 💬10. Dexamethasone
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [22] 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬 [22] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299💬 ... 10. Dexamethasone
|